Lucy scientific discovery inc. receives nasdaq notification of non-compliance with listing rule 5250(c)(1)

Vancouver, british columbia--(business wire)--lucy scientific discovery inc. (nasdaq: lsdi), a company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for june 25, 2024 before a nasdaq hearings panel (the “panel”) regarding its plan to regain compliance with nasdaq listing rule 5550(b) (the “stockholders' equity rule”). on may 21, 2.
NDAQ Ratings Summary
NDAQ Quant Ranking